554
Participants
Start Date
August 22, 2019
Primary Completion Date
December 1, 2025
Study Completion Date
January 1, 2026
Lipiodol UltraFluid
The investigational product is an oil-based contrast medium, Lipiodol® (Guerbet). Lipiodol® is a solution of ethyl esters of iodized fatty acids of poppy seed oil equivalent to 480mg I /ml and is a licensed contrast agent in the Netherlands (RVG 02806, see SmPC D2). The maximum amount of Lipiodol® per HSG procedure is 15 ml.
RECRUITING
Amsterdam AMC, Amsterdam
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Amsterdam UMC, location VUmc
OTHER